Hadassah

Thyroid Cancer Diagnosis Enhanced at Hadassah Using Advanced Gene Sequencing

Thursday, Aug 2 2018

left: Dr.Iddo Ben-Dov and right: Prof.Haggi Mazeh

Hadassah Medical Organization researchers, using next generation sequencing (NGS), have identified a highly accurate RNA panel that distinguishes thyroid cancer from benign nodules.

The study, authored by Prof. Haggi Mazeh, Chief of Surgery at Hadassah Hospital Mount Scopus, and Hadassah Nephrologist Dr. Iddo Ben-Dov, is highlighted in the July 26, 2018 on line issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

As the authors explain, fine needle aspiration biopsy (FNAB), the gold-standard procedure for diagnosing malignant thyroid nodules, yields indeterminate cytology in 10 to 40 percent of cases. The aim of their study was to utilize NGS technology to identify diversities in the microRNA expression profile of benign versus malignant thyroid nodules. MicroRNAs are short, non-coding RNAs that regulate cell function and play a role in cancer development.

"Thyroid nodules are extremely common and occasionally harbor cancer," explains Prof. Mazeh. "Patients who undergo evaluation of thyroid nodules often receive ambiguous results, and there are currently limited options for further management, representing a clinically unmet need."

“Our panel,” the researchers concluded, “may classify indeterminate thyroid nodules with higher accuracy than commercially available molecular tests.”

Read more about this study in Medical Xpress.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Aug 15 2019

Argentinian Neurosurgeon Shares His Love for Working at Hadassah

Many years ago, neurosurgeon Andrés Vargas, born in Tucumán, Argentina, chose to live in Israel and practice medicine at Hadassah Hospital Ein Kerem.

READ MORE ›
alt_text

Wednesday, Aug 14 2019

A Hadassah Cystic Fibrosis Expert Advises the Panamanian Government

Dr. Malena Cohen, a pediatric pulmonary specialist at the Hadassah Medical Organization, traveled to Panama last week to explore the idea of opening the first cystic fibrosis (CF) center there.

READ MORE ›
alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More